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Abstract 
Objective: For the past 10 years, refugees from Eritrea represented the majority of asylum seekers in Switzerland. 
However, data on their health status remains limited. In this cross‑sectional survey followed by a 1‑year cohort study, 
we screened newly arrived Eritrean refugees for cardiovascular risk factors at arrival and 1‑year post registration.
Results: Among 107 participants (88.8% male; median age 25, 9 (9%) had a body mass index ≥ 25 kg/m2, one (1%) 
had elevated blood pressure, one (1%) had diabetes, 19% smoked and two (2%) had a low density lipoprotein (LDL) 
cholesterol ≥ 4.1 mmol/l. Among the 48 participants (5 females, 43 males) followed, there were no significant changes 
in cardiovascular risk profile 1 year post‑arrival.
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Introduction
In the past decade high numbers of refugees arrived in 
Europe. Focus of research on migrants’ health in host 
countries has mainly been on communicable infectious 
diseases. Little attention was given to the prevalence of 
cardiovascular diseases (CVDs) and their risk factors. 
However, CVDs are known to be on the rise in many 
African countries, including major source countries of 
refugees arriving in Europe [1].
The few studies available report adaption of new life 
style among immigrants in host countries exposing them 
to a higher CVD risk [2]. A US study revealed at least one 
non-communicable disease in more than half of recently 
arrived adult refugees [3]. Frequently diagnosed CVD 
risk factors are; high body mass index (BMI), elevated 
blood pressure (BP), and smoking. In a study conducted 
in Canada, 30% of refugees screened had elevated BP [4]. 
Médecins sans Frontières reports a 20.9% prevalence of 
CVDs among Syrian refugees arriving in Jordan [5].
There is, however, nearly no data on CVD risk profile 
among African migrants arriving in Europe. Switzerland 
is one of the major destinations of Eritrean refugees. 
During the last decade, the majority of African migrants 
in Switzerland, accounting for almost 30%, were Eritrean 
origin [6]. In this cohort-study we report CVD risk pro-
file among Eritrean refugees at arrival and its change 
1 year post arrival in Switzerland.
Main text
Methods
In two Swiss cantons (Basel-Stadt, Basel-Land), we 
enrolled Eritrean refugees from February to November 
2016. After a written consent to take part in the study, 
participants were screened for infectious and non-infec-
tious diseases at baseline and thereafter followed for 
12  months. Detailed recruitment procedure and results 
from infectious diseases screening has been described 
previously [7]. In this short communication we report 
from the same cohort the CVD risk profile at baseline 
and 1-year follow-up.
Study participants were eligible if they were aged 
16  years and above, had arrived less than 1  year ago in 
Switzerland, had no physical complaints at recruitment 
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and consented to the study. The recruitment period was 
driven by the study budget. We used a convenience sam-
ple-size including all individuals found eligible during the 
study-period.
For CVD risk profile screening, they were inter-
viewed about life-style habits and smoking, thereafter, 
body-weight and height, waist circumference and blood 
pressure were measured. Thereafter venous blood was 
collected at fasting state for measurement of glycated 
hemoglobin (HbA1c) and lipid-panel [total cholesterol 
(TC), high density lipoprotein (HDL), low density lipo-
protein (LDL), and triglycerides (TG)]. Screening was 
done at baseline and participants were re-contacted 
1 year later for follow-up.
Data were collected on paper format and subsequently 
entered into EpiInfo version 7 (CDC, 1600 Clifton Road, 
Atlanta, USA). Statistical analyses were performed in 
Stata version 13 (StataCorp LP, 4905 Lakeway Drive, Col-
lege Station, USA).
The study protocol was approved by the institutional 
research commission of the Swiss Tropical and Public 
Health Institute (Swiss TPH, Basel, Switzerland; refer-
ence no. FK 120; approval date: June 24, 2015) and the 
Ethics Committee of Northwest and Central Switzerland 
(reference no. EKNZ 2015-353; approval date: November 
20, 2015). Participation was voluntary and people could 
withdraw from the study at any time without further 
obligations.
Results
A total of 107 (11.2% female) refugees were enrolled at 
baseline. Median age was 25 (interquartile range [IQR] 
20–28) years. Table  1 presents prevalence of CVDs risk 
factors at baseline. Generally, participants had a favoura-
ble CVD risk profile at arrival. Overall, 48 (45%) attended 
the 1-year follow-up visit. The remaining had either 
moved to a different canton or outside Switzerland (45%) 
or declined participation at follow-up visit (10%). Table 2 
compares baseline and follow-up measures among the 48 
participants with complete data. There was no significant 
change in median blood pressure and cholesterol values 
at 1 year follow-up. However, BMI and HbA1c showed a 
very small, but significant trend of change.
Discussion
In this cohort study Eritrean refugees had a very 
favourable CVD risk profile at arrival in Switzerland 
and CVD risk factors did not show any relevant change 
1  year post arrival in the host country. This study has 
several limitations. First, most study participants were 
in their young age (median 24  years) where generally 
the CVD risk profile is low. Second, only half of partici-
pants could be followed at 1 year due to high numbers 
of participants moving to different areas in Switzerland 
or Europe. Third, the follow-up period of 1-year was 
rather short.
Table 1 Cardio-vascular risk factors among  newly arrived 
Eritrean refugees in Switzerland
IQR interquartile range, NA not applicable
Measures Variable 
(unit)
Categories N (%) Median (IQR)
Age Age (years) 107 (100.0) 25 20–28
Smoking Smoking Non‑smoker 83 (77.6) NA NA
Ex‑smoker 4 (3.7) NA NA
Smoker 20 (18.7) NA NA
Body mass 
index
BMI (kg/m2) Over all 107 (100.0) 21.2 19.4–23.1
< 18.5 15 (14.0) 17.1 16.8–18.2
≥ 18.5 
and ≤ 24.9
83 (77.6) 21.7 20.1–22.9
≥ 25.0 9 (8.6) 27.2 26.5–28.1
Blood 
pressure
SBP (mmHg) Over all 117 109–122
< 120 67 (62.6) 112 103–116
≥ 120 
and ≤ 139
39 (36.4) 123 121–129
≥ 140 1 (0.9) 140 NA
DBP 
(mmHg)
Over all 70 64–77
< 80 93 (86.9) 68 63–73
≥ 80 
and ≤ 89
13 (12.1) 83 81–87
≥ 90 1 (0.9) 99 NA
Glycated 
hemo‑
globin
HbA1c (%) Over all 5.0 4.8–5.2
< 5.6 99 (92.5) 4.9 4.7–5.1
≥ 5.6 
and < 6.5
7 (6.5) 5.7 5.7–5.9
≥ 6.5 1 (0.9) 6.6 NA
Lipid 
panel
TC (mmol/L) Over all 3.9 3.3–4.5
< 5.16 99 (92.5) 3.8 3.1–4.2
≥ 5.16 
and < 6.20
5 (4.7) 5.6 5.4–5.7
≥ 6.20 3 (2.8) 6.8 6.5–6.8
LDL 
(mmol/L) 
Over all 2.2 1.8‑2.7
< 3.35 100 (93.5) 2.1 1.5–2.5
≥ 3.35 
and < 4.10
5 (4.7) 3.5 3.5–3.7
≥ 4.10 2 (1.9) 4.6 4.4–4.9
HDL 
(mmol/L) 
Over all 1.2 1.0–1.4
< 3.0 107 (100.0) 1.1 1.0–1.4
≥ 3.0 0 (0.0) NA NA
Triglycerides 
(mmol/L)
Over all 0.9 0.7–1.3
< 2.26 104 (97.2) 1.0 0.7–1.2
≥ 2.26 
and < 4.50
3 (2.8) 2.9 2.4–3.1
≥ 4.50 0 (0.0) NA NA
TC to HDL 
ratio
< 3.0 45 (42.1) 2.5 2.1–2.7
≥ 3.0 62 (57.9) 3.6 3.3–4.3
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In summary, our data are in line with survey data 
from Eritrea where the CVD risk profile in the general 
population was very low [8]. In our study, young Eri-
trean refugees had a very favorable CVD risk profile 
and showed no relevant increase in body-weight, cho-
lesterol levels, blood pressure or blood glucose 1  year 
after arrival in Switzerland.
Limitations
• Small sample size of participants.
• Relatively low participation of female refugees.
• Short follow-up time.
Table 2 Trend of  lipid panel change at  base-line and  1  year follow-up among  recently migrated Eritrean refugees 
to Switzerland
IQR interquartile range, NA not applicable
Parameters Categories Base-line Follow-up N = 48
N (%) Median (IQR) N (%) Median (IQR) Statistics
BMI
 Body mass index (kg/m2) Over all 48 (100.0) 21.7 19.2–23.1 48 (100.0) 22.2 19.2–23.1 t(47) = − 2.56; p = 0.01
< 18.5 7 (14.6) 17.5 16.3–18.3 5 (10.4) 17.5 16.8–18.2
≥ 18.5 and ≤ 24.9 34 (70.8) 21.7 20.1–22.6 36 (75.0) 22.0 21.0–23.1
≥ 25.0 7 (14.6) 27.2 26.5–28.3 7 (14.6) 27.9 25.6–28.3
Blood pressure
 Systolic blood pressure (mmHg) Over all 48 (100.0) 115.2 108.5–120.5 48 (100.0) 112.5 108.5–120.0 t(47) = 1.15; p = 0.26
< 120 32 (66.7) 112.0 104.0–115.5 35 (72.9) 111.0 106.0–114.0
≥ 120 and ≤ 139 16 (33.3) 124.5 120.5–130.5 13 (27.1) 124.0 123.0–126.0
≥ 140 0 0
 Diastolic blood pressure (mmHg) Over all 48 (100.0) 71.0 64.0–77.0 48 (100.0) 68 63.0–72.5 t(47) = 1.43; p = 0.16
< 80 46 (95.8) 70.5 64.0–76.0 45 (93.8) 66 63.0–71.0
≥ 80 and ≤ 89 2 (4.2) 83.5 80.0–87.0 3 (6.2) 81 81.0–84.0
≥ 90 0 0
HbA1c
 Glycated hemoglobin (%) Over all 48 (100.0) 5.0 4.8–5.1 48 (100.0) 5.0 5.0–5.2 t(47) = − 3.44; p = 0.001
< 5.6 45 (93.8) 5.0 4.8–5.1 45 (93.8) 5.0 5.0–5.2
≥ 5.6 and < 6.5 3 (6.2) 5.7 5.6–5.8 3 (6.2) 5.8 5.7–6.1
≥ 6.5 0 0
Cholesterol
 Total Cholesterol [TC] (mmol/L) Over all 48 (100.0) 4.0 3.3–4.6 48 (100.0) 4.0 3.4–4.6 t(47) = 0.80; p = 0.43
<5.16 42 (87.5) 3.9 3.2–4.4 43 (89.6) 3.9 3.3–4.3
≥ 5.16 and < 6.20 4 (8.3) 5.5 5.4–5.8 5 (10.4) 5.4 5.3–5.4
≥ 6.20 2 (4.2) 6.7 6.5–6.8 0
 Low density lipoprotein [LDL] 
(mmol/L)
Over all 48 (100.0) 2.3 1.8–3.0 48 (100.0) 2.2 1.7–2.5 t(47) = 1.94; p = 0.06
< 3.35 43 (89.6) 2.1 1.7–2.5 45 (93.8) 2.1 1.6–2.4
≥ 3.35 and < 4.10 4 (8.3) 3.5 3.5–3.7 3 (6.2) 3.9 3.5–3.9
≥ 4.10 1 (2.1) 4.4 NA 0
 High density lipoprotein [HDL] 
(mmol/L)
Over all 48 (100.0) 1.2 1.0–1.5 48 (100.0) 1.3 1.1–1.4 t(47) = 0.11; p = 0.92
< 3.0 48 (100.0) 1.2 1.0–1.5 48 (100.0) 1.3 1.1–1.4
≥ 3.0 0 0
 Triglycerides (mmol/L) Over all 48 (100.0) 1.0 0.8–1.4 48 (100.0) 1.0 0.8–1.4 t(47) = − 1.59; p = 0.12
< 2.26 48 (100.0) 1.0 0.8–1.4 43 (89.6) 1.0 0.8–1.2
≥ 2.26 and < 4.50 0 4 (8.3) 2.6 2.3–3.0
≥ 4.50 0 1 (2.1) 5.3 NA
 TC to HDL ratio Over all 48 (100.0) 3.2 2.8–3.8 48 (100.0) 3.0 2.8–3.7 t(47) = 1.08; p = 0.29
< 3.0 18 (37.5) 2.6 2.4–2.9 21 (43.8) 2.8 2.5–2.9
≥ 3.0 30 (62.5) 3.7 3.2–4.4 27 (56.2) 3.5 3.2–4.2
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